Maison Solutions (MSS)
Search documents
Important Notice to Long-Term Shareholders of Maison Solutions Inc. (MSS): Securities Fraud Class Action Approaches Settlement and Grabar Law Investigates Claims on Your Behalf
Newsfile· 2025-11-13 13:11
Core Viewpoint - A securities fraud class action against Maison Solutions Inc. has survived a motion to dismiss, and the case is currently stayed as parties attempt to reach a settlement [3][4]. Group 1: Allegations and Legal Proceedings - The class action complaint alleges that Maison Solutions made materially false and misleading statements in its Registration Statement and throughout the Class Period (October 5, 2023 to December 15, 2023) [3]. - Key allegations include the failure to disclose that vendor XHJC Holdings Inc. is a related party, and that the CEO and related entities allegedly used supermarkets to defraud the EB-5 visa program [3]. - As a result of these allegations, the positive statements made by the defendants regarding the company's business and prospects were deemed materially misleading [3]. Group 2: Shareholder Actions - Current shareholders who purchased shares on or shortly after the October 5, 2023 IPO may seek corporate reforms, the return of funds to the company, and a court-approved incentive award at no cost [2][5]. - Shareholders are encouraged to contact Grabar Law Office for further information and assistance regarding their claims [2][5].
Grabar Law Office Investigates Claims on Behalf of Shareholders of Maison Solutions Inc. (NASDAQ: MSS) as Securities Fraud Class Action Survives Motion to Dismiss and Approaches Settlement
Globenewswire· 2025-11-07 14:41
PHILADELPHIA, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of shareholders of Maison Solutions Inc. (NASDAQ: MSS) as an underlying securities fraud class action has survived a motion to dismiss the complaint and is now stayed pending attempts to settle the case. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you are a current Maison Solutions Inc. (NASDAQ: MSS) shareholder who purchased Mai ...
Grabar Law Office Investigates Claims on Behalf of Shareholders of Maison Solutions Inc. (NASDAQ: MSS) as Securities Fraud Class Action Survives Motion to Dismiss
Globenewswire· 2025-11-05 23:02
PHILADELPHIA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of shareholders of Maison Solutions Inc. (NASDAQ: MSS) as an underlying securities fraud class action has survived a motion to dismiss the complaint. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you are a current Maison Solutions Inc. (NASDAQ: MSS) shareholder who purchased Maison shares on or near its October 5, 2023 IPO and stil ...
Maison Solutions Purchases Over 2.55 Million Worldcoin (WLD) Tokens Under Treasury Initiative
Accessnewswire· 2025-11-03 13:30
MONTEREY PARK, CA / ACCESS Newswire / November 3, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced the purchase of approximately 2.55 million Worldcoin (WLD) tokens for its Digital Asset Treasury ("DAT") initiative. "I am pleased to announce the official launch of our WLD treasury initiative, marked by the purchase of over 2.55 million WLD," said Maison Solutio ...
Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting
Globenewswire· 2025-10-30 13:01
Core Insights - Xilio Therapeutics, Inc. is set to present late-breaking data on vilastobart, a tumor-activated anti-CTLA-4 therapy, at the SITC 40th Annual Meeting from November 5-9, 2025 [1] - The Phase 2 data will focus on the response rate of vilastobart in combination with atezolizumab for patients with microsatellite stable metastatic colorectal cancer and high plasma tumor mutational burden [1] Presentation Details - The abstract title for the presentation is "Plasma Tumor Mutational Burden (pTMB) Enriched for Response to Vilastobart in Combination with Atezolizumab in Patients with Microsatellite Stable (MSS) Metastatic Colorectal Cancer" [2] - The late-breaking abstract number is 1315, and the presentation is scheduled for November 7, 2025, from 9:00 a.m. to 7:00 p.m. EST at the Gaylord National Resort and Convention Center [2] Company Overview - Xilio Therapeutics is a clinical-stage biotechnology company focused on developing tumor-activated immuno-oncology therapies aimed at improving cancer treatment outcomes while minimizing systemic side effects [3] - The company utilizes a proprietary platform to advance a pipeline of novel tumor-activated immuno-oncology molecules designed to enhance therapeutic efficacy within the tumor microenvironment [3]
Halper Sadeh LLC Encourages Maison Solutions Inc. Shareholders to Contact the Firm to Discuss Their Rights
Businesswire· 2025-10-24 12:40
Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Maison Solutions Inc. (NASDAQ: MSS) towards shareholders [1] Group 1 - The investigation pertains to whether the actions of the company's leadership have harmed shareholder interests [1] - Shareholders who acquired Maison stock on or before October 5, 2023, may have the opportunity to seek various forms of corporate governance reforms [1] - Potential outcomes for shareholders include the return of funds to the company, a court-approved financial incentive award, or other relief and benefits [1]
Maison Solutions(MSS.US)股价狂飙!拟筹资7000万美元打造Worldcoin数字资产金库
Zhi Tong Cai Jing· 2025-09-29 13:37
Core Insights - Maison Solutions (MSS.US) has signed a securities purchase agreement with a U.S. institutional investor to issue up to $70 million in convertible notes through a private placement [1] - The raised funds will be used to initiate a digital asset treasury centered around Worldcoin (WLD), the native token of the World Network [1] - The company plans to explore blockchain-related initiatives, including cross-border payments using WLD as a reserve asset, financial inclusion for underserved customers, and identity verification-based anti-fraud loyalty programs [1] Company Developments - Maison Solutions may consider deploying Worldcoin Orb devices in stores for offline identity verification, although it has not yet applied to join the World Network or received approval for Orb deployment [1] - Following the announcement, Maison Solutions' stock surged over 305% in early trading on Monday [1] Industry Context - Worldcoin, co-founded by OpenAI's Sam Altman, aims to provide a critical "Proof of Human" solution for an increasingly AI-driven world [2] - The project has developed unique spherical iris-scanning hardware (Orb) that allows users to verify their unique human identity through iris scanning to participate in Worldcoin transactions [2] - Worldcoin utilizes zero-knowledge proof technology to confirm a user's authenticity without storing biometric information on the blockchain [2] - The project has created nearly 16 million zero-knowledge human proof accounts across over 45 countries since its launch in July last year [2]
MAISON SOLUTIONS (MSS) ALERT: Bragar Eagel & Squire, P.C. is Investigating Maison Solutions on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-27 12:11
Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Maison Solutions Inc. (NASDAQ: MSS) on behalf of long-term stockholders due to a class action complaint filed against the company, alleging breaches of fiduciary duties by the board of directors [1][7]. Group 1: Legal Investigation - The investigation is prompted by a class action complaint filed on January 2, 2024, concerning Class A common stock related to the company's initial public offering (IPO) and securities from October 5, 2023, to December 15, 2023 [1][7]. - The complaint alleges that the Offering Documents were negligently prepared, containing untrue statements of material fact and failing to disclose necessary facts, including the engagement of auditors and underwriters with poor track records and undisclosed related party transactions [7]. Group 2: IPO Details - Maison Solutions conducted its IPO between October 5, 2023, and October 10, 2023, issuing 2,500,000 common shares at an offering price of $4.00 per share, resulting in approximately $10 million in proceeds before expenses [7]. - The Offering Documents, which included the registration statement and prospectus, were declared effective on September 29, 2023, after multiple amendments [7].
Maison Solutions Reports First Quarter 2026 Financial Results
Accessnewswire· 2025-09-22 20:59
Core Insights - Maison Solutions Inc. reported financial results for the first quarter ended July 31, 2025, highlighting its focus on growth through mergers and acquisitions [1] Financial Performance - The company is a U.S.-based specialty grocery retailer that offers traditional Asian and international food and merchandise [1] Management Commentary - John Xu, the CEO of Maison Solutions, emphasized that mergers and acquisitions remain a core lever for the company's growth strategy [1]
Maison Solutions (MSS) - 2026 Q1 - Quarterly Report
2025-09-22 20:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) For the quarterly period ended July 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File No. 001-41720 Maison Solutions Inc. (Exact name of registrant as specified in its charter) | Delaware | 84-2498797 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or orga ...